Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer.
MUC4 is a large, heavily glycosylated transmembrane mucin, that is implicated in the pathogenesis of various types of cancers. To date, no extensive study has been done to check the expression and functional significance of MUC4 in different types of gastric adenocarcinomas. Here, we report the expression profile of MUC4 in gastric adenocarcinomas and its function in poorly differentiated gastric non-signet ring cell carcinoma (non-SRCC) type cells. Immunohistochemical analysis using tissue microarray (TMA) showed a significant difference in MUC4 expression between normal adjacent (n = 45) and gastric adenocarcinoma (n = 83; P < 0.001). MUC4 expression was not associated with tumour type, stage or with the degree of differentiation. To gain further insight into the significance of MUC4 expression in gastric non-SRCC cells, MUC4 was ectopically expressed in AGS, a poorly differentiated gastric non-signet ring cell line. The MUC4 overexpressing cells (AGS-MUC4) showed a significant increase (P < 0.005) in cell motility and a decrease in cellular aggregation as compared with the vector-transfected cells. Furthermore, in vivo tumorigenicity analysis revealed that animals transplanted with the MUC4 overexpressing cells (AGS-MUC4) had a greater incidence of tumours (83%) in comparison to empty vector control (17%). In addition, the expression of MUC4 resulted in enhanced expression of total cellular ErbB2 and phosphorylated ErbB2. In conclusion, our results showed that MUC4 is overexpressed in gastric adenocarcinoma tissues, and that it has a role in promoting aggressive properties in poorly differentiated gastric non-SRCC cells through the activation of the ErbB2 oncoprotein.
Senapati
S
S
Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaho, NE 68198, USA.
Chaturvedi
P
P
Sharma
P
P
Venkatraman
G
G
Meza
J L
JL
El-Rifai
W
W
Roy
H K
HK
Batra
S K
SK
D000230:Adenocarcinoma / Q000378:metabolism* / Q000556:secondary; D000818:Animals; D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism; D018279:Carcinoma, Signet Ring Cell / Q000378:metabolism* / Q000556:secondary; D002454:Cell Differentiation; D002465:Cell Movement / Q000502:physiology; D005455:Fluorescent Antibody Technique; D005753:Gastric Mucosa / Q000378:metabolism / Q000473:pathology; D006801:Humans; D015151:Immunoblotting; D007124:Immunoenzyme Techniques; D047468:Immunoprecipitation; D051379:Mice; D008819:Mice, Nude; D055264:Mucin-4 / Q000378:metabolism*; D009367:Neoplasm Staging; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D013274:Stomach Neoplasms / Q000378:metabolism* / Q000473:pathology*; D046888:Tissue Array Analysis; D014162:Transfection; D014407:Tumor Cells, Cultured
D014408:Biomarkers, Tumor; D055264:Mucin-4; D018719:Erb-b2 Receptor Tyrosine Kinases
Nat Rev Cancer. 2005 May;5(5):341-54
15864276
Int J Cancer. 1998 Apr 17;79(2):133-8
9583726
Gastroenterology. 1997 Aug;113(2):455-64
9247464
Oncogene. 2000 Nov 20;19(49):5680-9
11114748
Oncogene. 2003 Sep 4;22(38):6107-10
12955090
Gastric Cancer. 2004;7(1):9-16
15052434
Gastroenterology. 1994 Jul;107(1):160-72
8020658
Br J Cancer. 2007 Aug 6;97(3):345-57
17595659
Br J Surg. 2003 Jan;90(1):95-101
12520583
Cancer Res. 1993 Feb 1;53(3):641-51
7678777
Am J Clin Pathol. 2002 May;117(5):791-6
12090430
Laryngoscope. 2004 Aug;114(8 Pt 2 Suppl 101):1-32
15284539
Biochem Biophys Res Commun. 2007 Mar 30;355(1):200-3
17292332
Acta Pathol Microbiol Scand. 1965;64:31-49
14320675
Cancer Res. 1995 Jun 15;55(12):2681-90
7780985
Adv Cancer Res. 1989;52:257-331
2662714
Gut. 2000 Sep;47(3):349-56
10940270
Cancer Detect Prev. 1995;19(2):173-82
7750105
Med J Aust. 1985 Feb 4;142(3):S5-6
3969029
Cancer Res. 1994 Apr 1;54(7 Suppl):1941s-1943s
8137316
Cancer Res. 2007 Jan 15;67(2):433-6
17234748
Eur J Cancer. 2008 May;44(7):1048-56
18397823
J Surg Oncol. 1999 Aug;71(4):214-9
10440758
Nat Rev Cancer. 2004 Jan;4(1):45-60
14681689
Mol Cancer Res. 2007 Apr;5(4):309-20
17406026
J Biol Chem. 2003 Sep 12;278(37):35458-64
12826677
Hepatology. 2004 Jan;39(1):220-9
14752841
Cancer Res. 1989 Dec 15;49(24 Pt 1):6966-71
2582438
Int J Cancer. 1998 Aug 21;79(4):402-10
9699534
Int J Cancer. 2003 May 10;104(6):683-94
12640674
Int J Cancer. 1989 Jun 15;43(6):1072-6
2471698
J Mammary Gland Biol Neoplasia. 1996 Apr;1(2):219-29
10887495
Pancreas. 2003 Apr;26(3):e48-54
12657964
J Histochem Cytochem. 2000 Mar;48(3):377-88
10681391
Cancer Res. 1983 Apr;43(4):1703-9
6831414
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
18287387
Mod Pathol. 2004 Feb;17(2):150-7
14657954
Curr Opin Cell Biol. 2005 Oct;17(5):559-64
16098726
Clin Cancer Res. 1998 Nov;4(11):2605-14
9829723
J Biol Chem. 1997 Dec 26;272(52):33245-54
9407114
Cancer Res. 2004 Jan 15;64(2):622-30
14744777
J Histochem Cytochem. 2000 Dec;48(12):1657-66
11101634
Hum Pathol. 1997 Sep;28(9):1056-65
9308730
Cancer Res. 2008 Apr 1;68(7):2065-70
18381409
Cancer. 1999 May 1;85(9):1894-902
10223227
Clin Cancer Res. 2001 Dec;7(12):4033-40
11751498